Letter to the Editor: Discussion on the suicide risk of CCB drugs: based on real-world drug safety surveillance

被引：0
|
作者：
Luo, Dongqiang [1 ]
Wu, Jiayu [2 ]
Liu, Bingshuo [3 ]
机构：
[1] Guangzhou Univ Chinese Med, Clifford Hosp, Guangzhou, Peoples R China
[2] Guangzhou Univ Chinese Med, Clin Coll 1, Guangzhou, Peoples R China
[3] Guangzhou Univ Chinese Med, Sch Clin Med 5, Guangzhou, Peoples R China
来源：
PSYCHOLOGICAL MEDICINE | 2024年 / 54卷 / 16期
关键词：
SIGNAL; SYSTEMS;
D O I：
10.1017/S003329172400254X
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：4930 / 4932
页数：3
相关论文
共 50 条
  • [1] Real-World Data, Advanced Analytics, and the Evolution of Postmarket Drug Safety Surveillance
    Dal Pan, Gerald J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 28 - 30
  • [2] A real-world drug safety surveillance study of lenvatinib from the FAERS database
    Yang, Yipin
    Wang, Yafen
    Chen, Bangjie
    Liu, Yuchen
    Gu, Kangsheng
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [3] Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
    Corrigan-Curay, Jacqueline
    Sacks, Leonard
    Woodcock, Janet
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (09): : 867 - 868
  • [4] Drug Safety and Relevant Issues in the Real-World
    Barbieri, Maria Antonietta
    Irrera, Natasha
    Convertino, Irma
    PHARMACEUTICALS, 2023, 16 (12)
  • [5] Letter to the Editor: Hepatocellular Carcinoma Surveillance in Cirrhosis Patients: Is the Real-World Situation Even Worse Than Reported?
    Huang, Daniel Q.
    Yeo, Yee Hui
    Nguyen, Mindie H.
    HEPATOLOGY, 2021, 74 (03) : 1714 - 1715
  • [6] Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database
    Yu, Mingming
    Zhou, Lijun
    Cao, Mengda
    Ji, Chunmei
    Zheng, Yuanyi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [7] Safety surveillance of longitudinal databases: results on real-world data
    Noren, G. Niklas
    Hopstadius, Johan
    Bate, Andrew
    Edwards, I. Ralph
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (06) : 673 - 675
  • [8] Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19"
    Takazono, Takahiro
    Fujita, Satoki
    Komeda, Takuji
    Miyazawa, Shogo
    Yoshida, Yuki
    Kitanishi, Yoshitake
    Kinoshita, Masahiro
    Kojima, Satoshi
    Shen, Huilian
    Uehara, Takeki
    Hosogaya, Naoki
    Iwanaga, Naoki
    Mukae, Hiroshi
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (11) : 2463 - 2467
  • [9] Real-world assessment of sparsentan's drug safety framework
    Fu, Wenjing
    Wang, Jingyu
    Xue, Yuzhou
    Pan, Dikang
    RENAL FAILURE, 2025, 47 (01)
  • [10] Real-world evidence in antiretroviral therapy: drug safety data
    Silva, Ana-Marta
    Pereira, Marta
    Dias, Claudia Camila
    Ventura, Angela
    Sousa-Pintobc, Bernardo
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2020, 24 (03): : 271 - 272
12345